-+ 0.00%
-+ 0.00%
-+ 0.00%

Reported Earlier, Basel Medical Group Prices $8.82M Initial Public Offering Of 2.205M Common Shares At $4/Share

Benzinga·02/26/2025 06:58:51
Listen to the news

The Company intends to use the net proceeds of the offering for (i) potential mergers and acquisitions, (ii) business expansion, such as additional clinic space, increasing auxiliary service capabilities, including X-ray, physiotherapy and laboratory testing services, hiring additional medical practitioners and staff, upgrading of technology systems, and bolstering of marketing expenditure, and (iii) daily operations and working capital.

Recently
Symbol
Price
%Change
  • --
  • 0%